Apellis Pharmaceuticals
Greg Boesch is an experienced professional in the pharmaceutical industry, currently serving as Associate Director of Drug Product Manufacturing and Technical Operations at Apellis Pharmaceuticals since March 2019. Prior to this role, Greg worked for Gilead Sciences from February 2011 to March 2019 as a Senior Research Associate II, focusing on formulation and process development for various preclinical and clinical projects. Greg possesses significant expertise in developing clinical solid oral dosage forms, including conventional and modified-release tablets. Academic credentials include a Bachelor of Science in Bioengineering from UCLA, earned in 2009, following education at Bellarmine College Preparatory from 2001 to 2005.
This person is not in any teams
This person is not in any offices
Apellis Pharmaceuticals
11 followers
Apellis Pharmaceuticals is a clinical stage biopharmaceutical company focused on the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.